List of Tables 5
List of Figures 8
Introduction 9
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections 9
Report Guidance 9
Clinical Trials by Region 10
Clinical Trials by Country 11
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 13
Top Five Countries Contributing to Clinical Trials in Europe 14
Top Countries Contributing to Clinical Trials in North America 15
Top Countries Contributing to Clinical Trials in Middle East and Africa 16
Top Five Countries Contributing to Clinical Trials in Central and South America
17
Clinical Trials by BRIC Nations 18
Clinical Trials by G7 Nations 19
Clinical Trials in G7 Nations by Trial Status 20
Clinical Trials by E7 Nations 21
Clinical Trials in E7 Nations by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Unaccomplished Trials of Methicillin-Resistant Staphylococcus Aureus (MRSA)
Infections 26
Subjects Recruited Over a Period of Time 29
Prominent Sponsors 30
Top Companies Participating in Methicillin-Resistant Staphylococcus Aureus (MRSA)
Infections Therapeutics Clinical Trials 32
Prominent Drug Comparison 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
AstraZeneca PLC 37
Clinical Trial Overview of AstraZeneca PLC 37
CrystalGenomics, Inc. 38
Clinical Trial Overview of CrystalGenomics, Inc. 38
Theravance, Inc. 39
Clinical Trial Overview of Theravance, Inc. 39
Merck & Co., Inc. 40
Clinical Trial Overview of Merck & Co., Inc. 40
Enanta Pharmaceuticals, Inc. 41
Clinical Trial Overview of Enanta Pharmaceuticals, Inc. 41
Nitric Biotherapeutics, Inc. 42
Clinical Trial Overview of Nitric Biotherapeutics, Inc. 42
PolyMedix, Inc. 43
Clinical Trial Overview of PolyMedix, Inc. 43
Veterans Biomedical Research Institute, Inc. 44
Clinical Trial Overview of Veterans Biomedical Research Institute, Inc. 44
Bio-K+ International Inc. 45
Clinical Trial Overview of Bio-K+ International Inc. 45
Lytix Biopharma AS 46
Clinical Trial Overview of Lytix Biopharma AS 46
Cempra Pharmaceuticals, Inc. 47
Clinical Trial Overview of Cempra Pharmaceuticals, Inc. 47
Harvard Pilgrim Health Care, Inc. 48
Clinical Trial Overview of Harvard Pilgrim Health Care, Inc. 48
Inhibitex, Inc. 49
Clinical Trial Overview of Inhibitex, Inc. 49
Wockhardt Limited 50
Clinical Trial Overview of Wockhardt Limited 50
3M Health Care 51
Clinical Trial Overview of 3M Health Care 51
Inova Health System 52
Clinical Trial Overview of Inova Health System 52
B. Braun Melsungen AG 53
Clinical Trial Overview of B. Braun Melsungen AG 53
Clinical Trial Overview of Top Universities / Institutes / Hospitals 54
Tel-Aviv Sourasky Medical Center 54
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 54
The National Institute of Allergy and Infectious Diseases 55
Clinical Trial Overview of The National Institute of Allergy and Infectious
Diseases 55
Hopitaux Universitaires de Geneve 56
Clinical Trial Overview of Hopitaux Universitaires de Geneve 56
University of California, Irvine 57
Clinical Trial Overview of University of California, Irvine 57
University of Pittsburgh 58
Clinical Trial Overview of University of Pittsburgh 58
The University of British Columbia 59
Clinical Trial Overview of The University of British Columbia 59
The University of Chicago 60
Clinical Trial Overview of The University of Chicago 60
Wilford Hall Medical Center 61
Clinical Trial Overview of Wilford Hall Medical Center 61
Uniformed Services University of the Health Sciences (USU) 62
Clinical Trial Overview of Uniformed Services University of the Health Sciences
(USU) 62
The Childrens Mercy Hospital 63
Clinical Trial Overview of The Childrens Mercy Hospital 63
John D. Dingell VA Medical Center 64
Clinical Trial Overview of John D. Dingell VA Medical Center 64
Veterans Affairs Medical Center 65
Clinical Trial Overview of Veterans Affairs Medical Center 65
University Hospital, Toulouse 66
Clinical Trial Overview of University Hospital, Toulouse 66
University of Colorado 67
Clinical Trial Overview of University of Colorado 67
CAMC Health System 68
Clinical Trial Overview of CAMC Health System 68
Boston Medical Center 69
Clinical Trial Overview of Boston Medical Center 69
University of Washington 70
Clinical Trial Overview of University of Washington 70
University of Kentucky 71
Clinical Trial Overview of University of Kentucky 71
University of Michigan 72
Clinical Trial Overview of University of Michigan 72
UMC Utrecht 73
Clinical Trial Overview of UMC Utrecht 73
Five Key Clinical Profiles 74
Appendix 109
Abbreviations 109
Definitions 109
Research Methodology 110
Secondary Research 110
About GlobalData 111
Contact Us 111
Disclaimer 111
Source 112
List of Tables
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, Global, Clinical Trials by Zone, 2011* 10
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, Global, Clinical Trials by Top Countries, 2011* 11
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, Global, Clinical Trials In Progress by Top Countries, 2011* 12
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, Asia-Pacific, Top Five Countries, 2011* 13
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, Europe, Top Five Countries, 2011* 14
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, North America, Top Countries, 2011* 15
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, Middle East and Africa, Top Countries, 2011* 16
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, Central and South America, Top Five Countries, 2011* 17
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, BRIC Countries, 2011* 18
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, G7 Countries, 2011* 19
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, G7 Countries, Clinical Trials by Trial Status, 2011* 20
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, E7 Countries, 2011* 21
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, E7 Countries, Clinical Trials by Trial Status, 2011* 22
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, Global, Clinical Trials by Phase, 2011* 23
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, Global, Clinical Trials In Progress by Phase 2011* 24
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, Global, Clinical Trials by Trial Status, 2011* 25
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, Global, Suspended Clinical Trials, 2011* 26
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, Global, Withdrawn Clinical Trials, 2011* 27
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, Global, Terminated Clinical Trials, 2011* 28
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 29
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, Global, Key Sponsors, 2011* 31
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, Global, Top Companies by Phase, 2011* 33
Methicillin-Resistant Staphylococcus Aureus (MRSA) InfectionsTherapeutics
Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 34
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011* 35
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011* 36
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2011* 37
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by CrystalGenomics, Inc., 2011*
38
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Theravance, Inc., 2011* 39
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011* 40
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Enanta Pharmaceuticals, Inc.,
2011* 41
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Nitric Biotherapeutics, Inc.,
2011* 42
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by PolyMedix, Inc., 2011* 43
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Veterans Biomedical Research
Institute, Inc., 2011* 44
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Bio-K+ International Inc.,
2011* 45
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Lytix Biopharma AS, 2011* 46
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Cempra Pharmaceuticals, Inc.,
2011* 47
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Harvard Pilgrim Health Care,
Inc., 2011* 48
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Inhibitex, Inc., 2011* 49
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Wockhardt Limited, 2011* 50
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by 3M Health Care, 2011* 51
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Inova Health System, 2011* 52
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by B. Braun Melsungen AG, 2011*
53
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical
Center, 2011* 54
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by The National Institute of
Allergy and Infectious Diseases, 2011* 55
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de
Geneve, 2011* 56
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by University of California,
Irvine, 2011* 57
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh,
2011* 58
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by The University of British
Columbia, 2011* 59
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by The University of Chicago,
2011* 60
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Wilford Hall Medical Center,
2011* 61
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Uniformed Services University
of the Health Sciences (USU), 2011* 62
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by The Childrens Mercy
Hospital, 2011* 63
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by John D. Dingell VA Medical
Center, 2011* 64
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Veterans Affairs Medical
Center, 2011* 65
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by University Hospital,
Toulouse, 2011* 66
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2011*
67
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by CAMC Health System, 2011* 68
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by Boston Medical Center, 2011*
69
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by University of Washington,
2011* 70
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2011*
71
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2011*
72
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials Market, Global, Clinical Trials by UMC Utrecht, 2011* 73
List of Figures
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, Global, Clinical Trials by Zone (%), 2011* 10
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, Global, Clinical Trials by Top Countries, 2011* 11
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, Global, Clinical Trials In Progress by Top Countries, 2011* 12
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 13
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, Europe, Top Five Countries (%), 2011* 14
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, North America, Top Countries (%), 2011* 15
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, Middle East and Africa, Top Countries (%), 2011* 16
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, Central and South America, Top Five Countries (%), 2011* 17
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, BRIC Countries (%), 2011* 18
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, G7 Countries (%), 2011* 19
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, G7 Countries, Clinical Trials by Trial Status, 2011* 20
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, E7 Countries (%), 2011* 21
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, E7 Countries, Clinical Trials by Trial Status, 2011* 22
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, Global, Clinical Trials by Phase (%), 2011* 23
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, Global, Clinical Trials In Progress by Phase, 2011* 24
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Market, Global, Clinical Trials by Trial Status, 2011* 25
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 29
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, Global, Key Sponsors, 2011* 30
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, Global, Top Companies by Phase, 2011* 32
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Therapeutics
Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 34
GlobalData Methodology 110 |
